Average Co-Inventor Count = 7.55
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (18 from 3,684 patents)
2. Viiv Healthcare UK (no.5) Limited (2 from 42 patents)
3. Syngene International Limited (2 from 7 patents)
4. Bristol Meyers Squibb Company (1 from 41 patents)
5. Viiv Healthcare UK Limited (9 patents)
19 patents:
1. 11505543 - 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication
2. 10954252 - Inhibitors of human immunodeficiency virus replication
3. 10544120 - Biaryl kinase inhibitors
4. 10253027 - Aryl lactam kinase inhibitors
5. 10246469 - Biaryl kinase inhibitors
6. 10035777 - Heterocyclic kinase inhibitors
7. 9737542 - Pyrrolotriazine kinase inhibitors
8. 9708337 - Aryl amide-based kinase inhibitors
9. 9527885 - Hepatitis C virus inhibitors
10. 8969564 - Aryl ether-base kinase inhibitors
11. 8957203 - Hepatitis C virus inhibitors
12. 8901305 - Aryl lactam kinase inhibitors
13. 8703953 - Aryl ether-base kinase inhibitors
14. 8691757 - Hepatitis C virus inhibitors
15. 8604024 - Compounds for the reduction of beta-amyloid production